LLY
805.71
-1.45%↓
UNH
556.95
-1.68%↓
JNJ
158.12
-1.16%↓
NVO
109.92
-1.81%↓
ABBV
200.71
-1.24%↓
LLY
805.71
-1.45%↓
UNH
556.95
-1.68%↓
JNJ
158.12
-1.16%↓
NVO
109.92
-1.81%↓
ABBV
200.71
-1.24%↓
LLY
805.71
-1.45%↓
UNH
556.95
-1.68%↓
JNJ
158.12
-1.16%↓
NVO
109.92
-1.81%↓
ABBV
200.71
-1.24%↓
LLY
805.71
-1.45%↓
UNH
556.95
-1.68%↓
JNJ
158.12
-1.16%↓
NVO
109.92
-1.81%↓
ABBV
200.71
-1.24%↓
LLY
805.71
-1.45%↓
UNH
556.95
-1.68%↓
JNJ
158.12
-1.16%↓
NVO
109.92
-1.81%↓
ABBV
200.71
-1.24%↓
Rezumat
Modificarea prețului
24h
Curent
Minim
8.25
Maxim
8.36
Recomandări | Neutru |
---|---|
Prognoză pe 12 luni | +35.87 upside |
Următoarele câștiguri | 12 nov. 2024 |
---|
Scor tehnic
By Trading Central
Încredere
Very Strong Bearish Evidence
8.24 / 8.54 Suport & Rezistență
Theravance Biopharma Inc Grafic
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
Știri relevante
3 nov. 2024, 23:05 UTC
Fitch Affirms Australia's Sovereign AAA Rating, But Warns Of Mounting Budget Risks
DJ
Citește
3 nov. 2024, 21:12 UTC
Westpac Says Annual Profit Falls 3%, Upbeat on Prospects -- Update
DJ
Citește
3 nov. 2024, 20:59 UTC
Westpac Says Annual Profit Falls 3%, Upbeat on Prospects
DJ
Citește
3 nov. 2024, 23:34 UTC
Stocks Poised for Lower Open -- Barrons.com
DJ
Citește
3 nov. 2024, 23:16 UTC
Berkshire Hathway Earnings Weren't as Bad as They Looked -- Barrons.com
DJ
Citește
3 nov. 2024, 22:50 UTC
Santos Says Working Interest in PNG LNG Now 39.9%
DJ
Citește
3 nov. 2024, 22:50 UTC
Santos Says Kumul to Assume $90 Million of Project Finance Debt Associated With Stake
DJ
Citește
3 nov. 2024, 22:49 UTC
Santos Says Final Payment Takes Total Cash Consideration to $602 Million
DJ
Citește
3 nov. 2024, 22:49 UTC
Santos Receives Final $241 Million Payment From Kumul
DJ
Citește
3 nov. 2024, 22:48 UTC
Santos Completes Sale of 2.6% Interest in PNG LNG to Kumul Petroleum
DJ
Citește
3 nov. 2024, 20:37 UTC
Westpac FY 2024 Deposits Increased 5% to A$674 Billion
DJ
Citește
3 nov. 2024, 20:37 UTC
Westpac FY 2024 Loans Increased 4% to A$807 Billion
DJ
Citește
3 nov. 2024, 20:37 UTC
Westpac FY 2024 Impairment Charges 7 Bps of Loans
DJ
Citește
3 nov. 2024, 20:37 UTC
Westpac FY 2024 Operating Expenses A$10.94 Billion, Up 7% Excluding Notable Items
DJ
Citește
3 nov. 2024, 20:36 UTC
Westpac FY 2024 Non-Interest Income A$2.84 Billion, Down 15%
DJ
Citește
3 nov. 2024, 20:35 UTC
Westpac FY 2024 CET1 Level 2 Capital Ratio 12.5%, Up 11 Bps
DJ
Citește
3 nov. 2024, 20:35 UTC
Westpac Raises Share Buyback Program by A$1 Billion
DJ
Citește
3 nov. 2024, 20:35 UTC
Westpac Final Dividend A$0.76/Share
DJ
Citește
3 nov. 2024, 20:33 UTC
Westpac FY 2024 Net Interest Margin Down 1 Bps at 1.95%
DJ
Citește
3 nov. 2024, 20:32 UTC
Westpac FY 2024 Revenue A$21.59 Billion, Flat on FY 2023
DJ
Citește
3 nov. 2024, 20:32 UTC
Westpac FY Net Profit A$6.99 Billion, Down 3%
DJ
Citește
3 nov. 2024, 18:09 UTC
Boeing Had a Big Week. This One Is Even Bigger. -- Barrons.com
DJ
Citește
3 nov. 2024, 10:30 UTC
Fed Prepares Rate Cut Amid Economic Contradictions -- WSJ
DJ
Citește
3 nov. 2024, 03:00 UTC
Disgraced Lebanese Central Banker Who Was a Fugitive Now Awaits His Fate -- WSJ
DJ
Citește
2 nov. 2024, 13:53 UTC
Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- Update
DJ
Citește
2 nov. 2024, 13:44 UTC
Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com
DJ
Citește
2 nov. 2024, 13:00 UTC
China's EV Makers Set Sights on Latin America in Global Expansion -- WSJ
DJ
Citește
2 nov. 2024, 12:58 UTC
Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com
DJ
Citește
2 nov. 2024, 12:48 UTC
Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- WSJ
DJ
Citește
2 nov. 2024, 12:32 UTC
Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com
DJ
Citește
Comparație
Modificare preț
Theravance Biopharma Inc Așteptări
Obiectiv de preț
By TipRanks
Prognoză pe 12 luni
Medie 11.25 USD 35.87%
Maxim 15 USD
Minim 9 USD
În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruTheravance Biopharma Inc - Dist în ultimele 3 luni.
Consens privind evaluarea
By TipRanks
Neutru
4 ratings
1
Cumpărare
3
Păstrare
0
Vânzare
Ținând cont de 4 analiști care au acordat evaluări ale acțiunilor Theravance Biopharma Inc - Dist în ultimele 3 luni.
Scor tehnic
By Trading Central
Termen scurt
Very Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Termen mediu
Weak Bearish Evidence
Recent bearish events outweigh bullish events.
Termen lung
Strong Bearish Evidence
All events are bearish.
Date financiare
$